We are live on ! Find out more
CNST

Constellation Pharmaceuticals, Inc.
CNST

Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

35 hedge funds and large institutions have $73M invested in Constellation Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TG
TRV GP
Massachusetts
+$28.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
3
CC
Casdin Capital
New York
+$12.5M
4
CAM
Cormorant Asset Management
Massachusetts
+$12.1M
5
O
OrbiMed
New York
+$7.96M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TG
1
TRV GP
Massachusetts
$20.4M +$28.9M +3,034,083 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.3M +$15.4M +1,618,545 New
CC
3
Casdin Capital
New York
$8.85M +$12.5M +1,314,743 New
CAM
4
Cormorant Asset Management
Massachusetts
$8.56M +$12.1M +1,271,687 New
O
5
OrbiMed
New York
$5.63M +$7.96M +835,842 New
VMI
6
VHCP Management II
New York
$4.89M +$6.92M +726,677 New
DM
7
Deerfield Management
New York
$4.28M +$6.06M +635,843 New
HIM
8
Hillhouse Investment Management
Cayman Islands
$2.14M +$3.03M +317,921 New
EC
9
EcoR1 Capital
California
$1.88M +$2.67M +280,000 New
BlackRock
10
BlackRock
New York
$1.28M +$1.81M +189,636 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$989K +$1.4M +146,881 New
Victory Capital Management
12
Victory Capital Management
Texas
$957K +$1.36M +142,230 New
BBA
13
Baker Bros. Advisors
New York
$897K +$1.27M +133,333 New
VMI
14
VHCP Management III
New York
$449K +$635K +66,667 New
DIM
15
DC Investments Management
Virginia
$351K +$497K +52,174 New
Northern Trust
16
Northern Trust
Illinois
$306K +$432K +45,384 New
SSA
17
Schonfeld Strategic Advisors
New York
$225K +$319K +33,500 New
Millennium Management
18
Millennium Management
New York
$160K +$227K +23,797 New
Goldman Sachs
19
Goldman Sachs
New York
$103K +$146K +15,301 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$79K +$112K +11,748 New
Deutsche Bank
21
Deutsche Bank
Germany
$68K +$96.3K +10,107 New
Morgan Stanley
22
Morgan Stanley
New York
$59K +$83.5K +8,766 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$41K +$58.1K +6,102 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$19K +$27.4K +2,880 New
AIG
25
American International Group
New York
$18K +$25.5K +2,679 New
1
2

CNST Hedge Fund Activity: Q3 2018 in Review

35 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2018, worth a combined $73M.

Buyers outnumbered sellers: 35 funds opened new CNST positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TRV GP, opening a new position worth an estimated $28.9M.

  • 35 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $73M of Constellation Pharmaceuticals, Inc. stock for Q3 2018.
  • 35 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2018 and 0 closed out, a net change of +35 holders.
  • The largest Constellation Pharmaceuticals, Inc. buyer in Q3 2018 was TRV GP, an estimated $28.9M added.

Based on aggregated 13F filings for Q3 2018.